| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;94:3355-3361.)
© 1996 American Heart Association, Inc.
Articles |
Inhibition of Transplant Coronary Arteriosclerosis in Rabbits by Chronic Estradiol Treatment Is Associated With Abolition of MHC Class II Antigen Expression
Georgetown University Medical Center, Washington, DC.
Correspondence to Marie L. Foegh, MD, DSc, Georgetown University Medical Center, 4000 Reservoir Rd NW, Building D, Room 398, Washington DC 20007. E-mail mfoegh@aol.com.
Background Accelerated coronary arteriosclerosis is a major complication in long-term survivors of cardiac transplantation. Estrogen prevents transplant arteriosclerosis in experimental cardiac and aortic allografts and may act by an immune mechanism.
Methods and Results New Zealand White rabbits immunosuppressed with cyclosporine were recipients of cardiac allografts from Dutch Belted rabbits. The recipients received either estradiol or placebo daily until they were killed 6 weeks later. Histological cross sections of the cardiac allograft were used for quantification of major histocompatibility complex (MHC) class II antigen expression, T lymphocytes, and macrophages by immunohistochemistry using monoclonal antibodies. MHC class II antigen expression was not detectable in allograft coronary arteries from any of the estradiol-treated recipients, whereas this antigen expression was present in the allograft coronary arteries from all the placebo-treated recipients. Macrophage and lymphocyte infiltration of the allograft coronary artery myointima was significantly less frequent in the estradiol-treated group. Rejection was moderate but slightly less in the estradiol-treated group. These findings were associated with a 60% decrease in allograft coronary artery myointimal thickening (determined by morphometry) in the estradiol-treated compared with the placebo-treated group.
Conclusions Estradiol treatment of cardiac allograft recipients abolishes MHC class II antigen expression in the coronary arteries and decreases macrophage infiltration in all three layers of the vessel wall, whereas T-lymphocyte infiltration is decreased only in the myointima. These findings are associated with estradiol inhibition of myointimal proliferation. Thus, estradiol treatment may have a beneficial effect on graft arteriosclerosis through immune mechanisms.
Key Words: arteries • transplantation • arteriosclerosis • rejection • antigens
This article has been cited by other articles:
 |
|
 |
|
  B. Antus, S. Liu, Y. Yao, H. Zou, E. Song, J. Lutz, and U. Heemann Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats Nephrol. Dial. Transplant., February 1, 2005; 20(2): 329 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Adamski and E. N. Benveniste 17{beta}-Estradiol Activation of the c-Jun N-Terminal Kinase Pathway Leads to Down-Regulation of Class II Major Histocompatibility Complex Expression Mol. Endocrinol., January 1, 2005; 19(1): 113 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Adamski, Z. Ma, S. Nozell, and E. N. Benveniste 17{beta}-Estradiol Inhibits Class II Major Histocompatibility Complex (MHC) Expression: Influence on Histone Modifications and CBP Recruitment to the Class II MHC Promoter Mol. Endocrinol., August 1, 2004; 18(8): 1963 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tsuda, I. Nishio, M. Weis, J. P. Cooke, K. Y. Lin, S. N. Panchal, S.Z. Gao, H. A. Valantine, T. N. Kledal, and E. S. Mocarski Sex Hormones and Asymmetric Dimethylarginine in Transplant Arteriosclerosis * Response Circulation, July 20, 2004; 110(3): e21 - e22. [Full Text] [PDF]
|
|
|
|
|
|
E. Tzortzakaki, C. Spilianakis, E. Zika, A. Kretsovali, and J. Papamatheakis Steroid Receptor Coactivator 1 Links the Steroid and Interferon {gamma} Response Pathways Mol. Endocrinol., December 1, 2003; 17(12): 2509 - 2518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Vongpatanasin, M. Tuncel, Z. Wang, D. Arbique, B. Mehrad, and I. Jialal Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1358 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Mendelsohn and R. H. Karas The Protective Effects of Estrogen on the Cardiovascular System N. Engl. J. Med., June 10, 1999; 340(23): 1801 - 1811. [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Huber, J. Kupperman, and M. K. Newell Hormonal Regulation of CD4+ T-Cell Responses in Coxsackievirus B3-Induced Myocarditis in Mice J. Virol., June 1, 1999; 73(6): 4689 - 4695. [Abstract] [Full Text]
|
|
|
|
 |
|
 S A Huber, J Kupperman, and M K Newell Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bcl 2 expression Lupus, June 1, 1999; 8(5): 384 - 387. [Abstract] [PDF]
|
|
|
|
 |
|
 C. H. Selzman, T. A. Whitehill, B. D. Shames, E. J. Pulido, B. C. Cain, and A. H. Harken The Biology of Estrogen-Mediated Repair of Cardiovascular Injury Ann. Thorac. Surg., March 1, 1998; 65(3): 868 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Reis, V. Bhoopalam, K. A. Zell, P. J. Counihan, A. J. C. Smith, S. Pham, and S. Murali Conjugated Estrogens Acutely Abolish Abnormal Cold-Induced Coronary Vasoconstriction in Male Cardiac Allografts Circulation, January 13, 1998; 97(1): 23 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saito, N. Motomura, H. Lou, P. W. Ramwell, M. L. Foegh, DSc, Sponsor:, and E. A. Lefrak SPECIFIC EFFECTS OF ESTROGEN ON GROWTH FACTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II ANTIGEN EXPRESSION IN RAT AORTIC ALLOGRAFT J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 803 - 810. [Abstract] [Full Text]
|
|